235 related articles for article (PubMed ID: 19126656)
1. Super competition as a possible mechanism to pioneer precancerous fields.
Rhiner C; Moreno E
Carcinogenesis; 2009 May; 30(5):723-8. PubMed ID: 19126656
[TBL] [Abstract][Full Text] [Related]
2. Genetic progression model for head and neck cancer: implications for field cancerization.
Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
[TBL] [Abstract][Full Text] [Related]
3. A genetic progression model of oral cancer: current evidence and clinical implications.
Braakhuis BJ; Leemans CR; Brakenhoff RH
J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
[TBL] [Abstract][Full Text] [Related]
4. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
Braakhuis BJ; Leemans CR; Brakenhoff RH
Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
[TBL] [Abstract][Full Text] [Related]
5. Disease mechanism and biomarkers of oral squamous cell carcinoma.
Brinkman BM; Wong DT
Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
[TBL] [Abstract][Full Text] [Related]
6. Current status of biomarkers in head and neck cancer.
Chang SS; Califano J
J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
[TBL] [Abstract][Full Text] [Related]
7. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
[TBL] [Abstract][Full Text] [Related]
8. Second field tumors: a new opportunity for cancer prevention?
Braakhuis BJ; Brakenhoff RH; Leemans CR
Oncologist; 2005 Aug; 10(7):493-500. PubMed ID: 16079316
[TBL] [Abstract][Full Text] [Related]
9. Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture.
Rubin H
Bioessays; 2011 Mar; 33(3):224-31. PubMed ID: 21254148
[TBL] [Abstract][Full Text] [Related]
10. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers and genetics in cancer development.
Hormi-Carver K; Souza RF
Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
14. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
Cohen EE
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
[No Abstract] [Full Text] [Related]
15. Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis.
Kopnin BP
Biochemistry (Mosc); 2000 Jan; 65(1):2-27. PubMed ID: 10702637
[TBL] [Abstract][Full Text] [Related]
16. A new marker determining clonal outgrowth.
Mao L
Clin Cancer Res; 2002 Jul; 8(7):2021-3. PubMed ID: 12114399
[No Abstract] [Full Text] [Related]
17. Cancer: the role of extracellular disease.
Schwartz L; Balosso J; Baillet F; Brun B; Amman JP; Sasco AJ
Med Hypotheses; 2002 Apr; 58(4):340-6. PubMed ID: 12027530
[TBL] [Abstract][Full Text] [Related]
18. [Oncogenes--"reckless drivers" on signal pathways controlling cell division].
Johansen T; Bjørkøy G
Tidsskr Nor Laegeforen; 1998 May; 118(12):1880-5. PubMed ID: 9638058
[TBL] [Abstract][Full Text] [Related]
19. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
